enGene Holdings Inc. Common Stock

NasdaqCM ENGN

enGene Holdings Inc. Common Stock Inventory for the quarter ending October 31, 2024: USD 0.00

enGene Holdings Inc. Common Stock Inventory is USD 0.00 for the quarter ending October 31, 2024. Inventory is the value of goods held by a company for sale or used in the production process.
  • enGene Holdings Inc. Common Stock Inventory for the quarter ending October 31, 2022 was USD 74.00 K.
Key data
Date Inventory Goodwill Total Assets Current Liabilities
Market news
SV Wall Street
NasdaqCM: ENGN

enGene Holdings Inc. Common Stock

CEO Mr. Ronald H. W. Cooper
IPO Date Feb. 1, 2022
Location Canada
Headquarters 7171 Rue Frederick Banting
Employees 31
Sector Healthcare
Industries
Biotechnology
Description

enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. Its lead product candidate is EG-70 (detalimogene voraplasmid), which is a non-viral immunotherapy to treat non-muscle invasive bladder cancer patients with carcinoma-in-situ (Cis), who are unresponsive to treatment with Bacillus Calmette-Guérin. The company was founded in 2023 and is based in Saint-Laurent, Canada.

StockViz Staff

February 7, 2025

Any question? Send us an email